Swiss Life Asset Management’s Twist Bioscience TWST Stock Holding History

Swiss Life Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$426K	Buy	+4,140	New	+$269K	﹤0.01%	1060

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Swiss Life Asset Management's TWST Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 4,140 shares worth $426K. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings.

219 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Swiss Life Asset Management held 4,140 shares of Twist Bioscience worth $426K as of Q2 2026.
Twist Bioscience was a new Swiss Life Asset Management position in Q2 2026.
Twist Bioscience made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1060 holding.
219 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.